It was reported that this was reported as a general comment that the physician expressed his concern when trying to revascularize a re-stenosed supera stent.It was indicated as having had much more resistance when trying to cross the lesion of a re-stenosed supera stent.Additionally it was also indicated having had a hard, uncrossable lesion with supera than with other similar restenosed competitor stents.Because of this concern, the physician decided not to use the supera stent.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record and similar incident review of the reported lot could not be conducted because the part and lot number was not provided.The reported patient effect of stenosis is listed in the supera peripheral stent system instructions for use as a potential adverse effect of peripheral percutaneous intervention.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that interaction with the re-stenosed supera stent resulted in the reported difficult to advance.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|